Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMagnetic Solutions has developed proprietary cGMP-grade ferrofluid-based immunomagnetic cell selection platforms. Their FerroSelect Array platform enables high-performance selectivity without columns or expensive consumables. The company’s products are integrated into workflows for research, clinical development, and commercial manufacturing of advanced therapies such as CAR-T cells. They have established a new $10M cGMP facility to support these efforts. No direct clinical trial results are reported as they provide enabling tools rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMagnetic Solutions.